Home
Latest
E-paper
Companies
Industry
Economy
Blueprint
Finance
Markets
Budget
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Immigration
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
India likely to get Omicron-specific vaccine by year-end, says SII chief
SII is working with Novavax to bring the Omicron-specific vaccine, as the nation continues to record a surge in the number of Covid-19 cases
UK drugs regulator halts approvals for Indian clinical trials firm
Marketing approval has been suspended for an antibiotic following concerns over integrity of trial data of Quest Life Sciences
